Top 5 Clinical Trials Shaping Medicine in 2025
From precision oncology to gene editing, these standout trials could redefine how to diagnose and treat rare diseases and cancer
Already a member? Log in here
FDA Approves Teal Wand as First At-Home Cervical Cancer Screening
Teal Health, the company manufacturing and distributing the test, says thousands of women are already on a waiting list for the assay
Already a member? Log in here
How Advances in T-Cell Receptor Profiling Can Boost Early Cancer Diagnosis
New developments in flow cytometry and molecular biology promise to improve the detection of rare cancers
Already a member? Log in here
Image-Based AI Touted as a New Weapon Against Rare Cancers
Studies by Paige demonstrate the greater accuracy that artificial intelligence potentially offers for pathologists
Already a member? Log in here
How the LDT Final Rule’s Exemptions Apply to Oncology Labs
Regulatory expert explores whether any exclusions might benefit cancer laboratories trying to navigate upcoming compliance deadlines
Already a member? Log in here